A phase 1 clinical trial shows safe, sustained, AAV-mediated expression of IL-1Ra in the human osteoarthritic knee joint

Journal:

Science Translational Medicine

Published:

2025-06-04

DOI:

10.1126/scitranslmed.adu9804

Affiliations:

10

Authors:

19

Go to article

Institutions	Authors	Share
Mayo Clinic, United States of America (USA)	14.000000 14.000000	0.74
Genascence Corp., United States of America (USA)	2.000000	0.11
NIHR Leeds Biomedical Research Centre, United Kingdom (UK)	1.000000	0.05
University of Minnesota (UMN), United States of America (USA)	1.000000	0.05
University of Florida Health (UF Health), United States of America (USA)	1.000000	0.05

Interested in Clinical Sciences?